Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

995 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal Cancer.
Zerillo JA, Schouwenburg MG, van Bommel ACM, Stowell C, Lippa J, Bauer D, Berger AM, Boland G, Borras JM, Buss MK, Cima R, Van Cutsem E, van Duyn EB, Finlayson SRG, Hung-Chun Cheng S, Langelotz C, Lloyd J, Lynch AC, Mamon HJ, McAllister PK, Minsky BD, Ngeow J, Abu Hassan MR, Ryan K, Shankaran V, Upton MP, Zalcberg J, van de Velde CJ, Tollenaar R; Colorectal Cancer Working Group of the International Consortium for Health Outcomes Measurement (ICHOM). Zerillo JA, et al. Among authors: van cutsem e, van duyn eb, van bommel acm, van de velde cj. JAMA Oncol. 2017 May 1;3(5):686-694. doi: 10.1001/jamaoncol.2017.0417. JAMA Oncol. 2017. PMID: 28384684
External radiotherapy and extrahepatic bile duct cancer.
Tollenaar RA, van de Velde CJ, Taat CW, Gonzalez Gonzalez D, Leer JW, Hermans J. Tollenaar RA, et al. Among authors: van de velde cj. Eur J Surg. 1991 Oct;157(10):587-9. Eur J Surg. 1991. PMID: 1687249
Antibodies against p53 are associated with poor prognosis of colorectal cancer.
Houbiers JG, van der Burg SH, van de Watering LM, Tollenaar RA, Brand A, van de Velde CJ, Melief CJ. Houbiers JG, et al. Among authors: van der burg sh, van de velde cj, van de watering lm. Br J Cancer. 1995 Sep;72(3):637-41. doi: 10.1038/bjc.1995.386. Br J Cancer. 1995. PMID: 7669574 Free PMC article.
Evidence of clonal divergence in colorectal carcinoma.
Tollenaar RA, Bonsing BA, Kuipers-Dijkshoorn NJ, Hermans J, van de Velde CJ, Cornelisse CJ, Fleuren GJ. Tollenaar RA, et al. Among authors: van de velde cj. Cancer. 1997 Apr 1;79(7):1304-14. Cancer. 1997. PMID: 9083151
Micrometastases and survival in stage II colorectal cancer.
Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, Tollenaar RA. Liefers GJ, et al. Among authors: van krieken jh, van de velde cj. N Engl J Med. 1998 Jul 23;339(4):223-8. doi: 10.1056/NEJM199807233390403. N Engl J Med. 1998. PMID: 9673300 Free article.
Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver.
Vahrmeijer AL, van Dierendonck JH, Keizer HJ, Beijnen JH, Tollenaar RA, Pijl ME, Marinelli A, Kuppen PJ, van Bockel JH, Mulder GJ, van de Velde CJ. Vahrmeijer AL, et al. Among authors: van dierendonck jh, van bockel jh, van de velde cj. Br J Cancer. 2000 May;82(9):1539-46. doi: 10.1054/bjoc.2000.1175. Br J Cancer. 2000. PMID: 10789721 Free PMC article. Clinical Trial.
Caspase-3 activity as a prognostic factor in colorectal carcinoma.
Jonges LE, Nagelkerke JF, Ensink NG, van der Velde EA, Tollenaar RA, Fleuren GJ, van de Velde CJ, Morreau H, Kuppen PJ. Jonges LE, et al. Among authors: van der velde ea, van de velde cj. Lab Invest. 2001 May;81(5):681-8. doi: 10.1038/labinvest.3780277. Lab Invest. 2001. PMID: 11351040 Free article.
995 results